Evidence map›Paper›PMID 38027639›Full record

ArticleHeliyon2023

Yinhuapinggan granule ameliorates lung injury caused by multidrug-resistant

Tianhang Chen, Haixia Du, Huifen Zhou, Yu He, Jiehong Yang, Chang Li, Chenxing Wei, Daojun Yu, Haitong Wan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tianhang ChenZhejiang Chinese Medical University, Hangzhou, 310053, China.
Haixia DuZhejiang Chinese Medical University, Hangzhou, 310053, China.
Huifen ZhouZhejiang Chinese Medical University, Hangzhou, 310053, China.
Yu HeZhejiang Chinese Medical University, Hangzhou, 310053, China.
Jiehong YangZhejiang Chinese Medical University, Hangzhou, 310053, China.
Chang LiZhejiang Chinese Medical University, Hangzhou, 310053, China.
Chenxing WeiAffiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Daojun YuAffiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Haitong WanZhejiang Chinese Medical University, Hangzhou, 310053, China.
Zhejiang Chinese Medical University · CNHangzhou First People's Hospital · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yinhuapinggan granule (YHPG) is a traditional Chinese medicine prescription with rich clinical experience for the treatment of colds and coughs. The aim of this study is to investigate the protective effect of YHPG on multidrug-resistant (MDR)

Indexed as

A.baumanniiInflammatory factorsNF-κB/NLRP3 signaling pathwayPneumoniaYinhuapinggan granule

Identifiers

PMID38027639
PMCPMC10661428
OpenAlexW4388210841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.